Monoclonal antibodies (mAbs) stimulate the immune system to mount a response to target antigens. In immunotherapy, scientists use mAbs to target various conditions, including cancer and autoimmune diseases. Despite technological and methodological advancements, researchers face challenges in mAb research. Therefore, they are developing optimized workflows to design, test, and produce mAbs efficiently and safely.
Download this infographic from Thermo Fisher Scientific to understand how researchers use mAbs to develop novel immunotherapies.
The Scientist c/o LabX Media Group
1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801
Toll Free: 888.788.0328 | Phone: 705.528.6888
Email: privacy@the-scientist.com
© 1986-2022 The Scientist
The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.